Relmada Therapeutics, Inc. · NASDAQ:RLMD
Relmada Therapeutics, Inc. shareholders
As of Jun 30, 2026, 123 institutions reported holding Relmada Therapeutics, Inc., 94.0% of its shares. Largest: Jupiter Topco LLC, BlackRock and Squadron Capital Management LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Relmada Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Jupiter Topco LLC | 11.2M | 10.5% | first report | Aug 14, 2026 |
| BlackRock | 7.43M | 7.0% | +6.14M | Aug 7, 2026 |
| Squadron Capital Management LLC | 7.35M | 6.9% | −1.12M | Aug 14, 2026 |
| Venrock Adviser, LLC | 6.84M | 6.4% | +2M | Aug 14, 2026 |
| Spruce Street Capital LP | 6.39M | 6.0% | +129K | Aug 13, 2026 |
| Vanguard | 6.14M | 5.8% | +2.58M | Aug 13, 2026 |
| Adage Capital Partners Gp, L.L.C. | 4.76M | 4.5% | no change | Aug 14, 2026 |
| Jones Hill Capital LP | 3.66M | 3.4% | +3.31M | Aug 13, 2026 |
| Orbimed Advisors LLC | 3.63M | 3.4% | −1.08M | Aug 14, 2026 |
| State Street | 2.52M | 2.4% | +2.16M | Aug 7, 2026 |